Skip to main content
. Author manuscript; available in PMC: 2021 Sep 4.
Published in final edited form as: Mult Scler. 2020 Dec 14;27(10):1506–1519. doi: 10.1177/1352458520971816

Table 5:

Comparison of dihydroceramide concentrations

Metabolite HC Mean (SD), ng/ml RRMS Mean (SD), ng/ml PMS Mean (SD), ng/ml HC v RRMS HC v PMS RRMS v PMS

Beta±SEa p-valuea Beta±SEa p-valuea Beta±SEa p-valuea

DH-Cer18:0 2.01
(3.52)
2.07
(3.15)
2.2
(3.95)
0.14±0.15 3.31E-01 0.13±0.17 4.29E-01 −0.01±0.14 9.40E-01

DH-Cer20:0 8.58
(5.76)
12.29
(6.43)
16.93
(6.99)
0.4±0.08 2.71E-06 0.76±0.1 3.38E-14 0.36±0.08 1.24E-05

DH-Cer22:0 21.99
(8.5)
24.12
(10.21)
28.31
(10.48)
0.06±0.06 3.84E-01 0.2±0.07 6.95E-03 0.14±0.06 2.15E-02

DH-Cer24:0 174.77
(72.93)
216.09
(81.15)
236.39
(90.48)
0.24±0.06 1.29E-04 0.29±0.07 7.20E-05 0.04±0.06 4.66E-01

DH-Cer26:0 1.93
(1.35)
2.42
(1.57)
3.03
(2.16)
0.21±0.09 1.56E-02 0.25±0.1 1.25E-02 0.04±0.08 6.58E-01

DH-HexCer16:0 8.67
(4)
9.11
(4.5)
10.51
(4.62)
0.001±0.07 9.95E-01 0.15±0.08 7.75E-02 0.15±0.07 3.73E-02

DH-HexCer18:0 0.83
(0.33)
0.88
(0.28)
0.89
(0.34)
0.06±0.05 2.14E-01 0.08±0.06 1.90E-01 0.01±0.05 7.95E-01

DH-HexCer20:0 4.59
(3.37)
4.36
(3.45)
5.44
(3.35)
−0.05±0.09 5.40E-01 0.2±0.1 4.67E-02 0.25±0.08 2.89E-03

DH-HexCer22:0 15.5
(5.77)
18.45
(6.52)
21.29
(8.1)
0.19±0.05 5.31E-04 0.33±0.06 1.25E-07 0.14±0.05 6.06E-03

DH-HexCer24:0 43.48
(16.6)
46.24
(16.76)
52.85
(17.81)
0.04±0.06 4.66E-01 0.16±0.07 1.94E-02 0.12±0.06 4.38E-02

DH-HexCer26:0 12.51
(12.16)
6.54
(6.02)
5.26
(4.92)
−0.61±0.12 3.00E-07 −0.82±0.13 2.49E-09 −0.2±0.11 6.96E-02

DH-LacCer16:0 8.35
(3.02)
8.17
(2.68)
9.07
(2.52)
−0.01±0.05 7.72E-01 0.15±0.05 3.37E-03 0.17±0.04 1.73E-04
a

Multivariable linear regression models including age, sex, race as covariates. Bolded p-values correspond to those that met the threshold of significance based on the Bonferroni correction.

HC: Healthy Controls; MS: Multiple Sclerosis; RRMS: Relapsing-Remitting MS; PMS: Progressive MS; SD: Standard Deviation; SE: Standard Error